Growth in global diabetic neuropathy market is highly attributed to consistently increasing diabetic population across the globe linked with growing awareness among people is considered as major market driver for diabetic neuropathy market. Moreover, global market is primarily driven by changing lifestyle which has mostly resulted into unhealthy dietary habits and patterns. In addition, factors such as increasing aging population, rise in healthcare expenditure for diabetes, growing awareness about diabetes, and rise in R&D activities in drug discovery and development have contributed in the global growth. However, growth of this market is predominantly restrained by longer approval time for drugs and side effects and rising cost of diabetic neuropathy treatment. Also, stringent regulatory requirement and significant failure rate during the clinical trials expected to be the growth barriers in the years to come.

Market Analysis and Insights: Global Diabetic Neuropathy Market
The global Diabetic Neuropathy market size is projected to reach US$ 5039.4 million by 2026, from US$ 4756.2 million in 2020, at a CAGR of 5.5%% during 2021-2026.

Global Diabetic Neuropathy Scope and Market Size
Diabetic Neuropathy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Neuropathy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Pfizer
Janssen Pharmaceuticals
Eli Lilly and Company
ACTAVIS
Cephalon
MEDA Pharma & Co. KG
GlaxoSmithKline
NeuroMetrix
Johnson and Johnson

Market segment by Type, the product can be split into

Peripheral Neuropathy
Autonomic Neuropathy
Proximal Neuropathy
Focal Neuropathy

Market segment by Application, split into

Hospitals
Clinics
Retail Pharmacy
Online Pharmacy

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India